Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

21.33
-1.0500-4.69%
Volume:816.82K
Turnover:17.74M
Market Cap:2.65B
PE:-168.14
High:22.53
Open:22.23
Low:21.33
Close:22.38
52wk High:31.77
52wk Low:11.86
Shares:124.03M
Float Shares:88.24M
Volume Ratio:0.56
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1269
EPS(LYR):-0.1269
ROE:-9.30%
ROA:-1.95%
PB:13.96
PE(LYR):-168.14

Loading ...

Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Jan 31, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

Major Issues Report

Form 8-K - Current report
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 16, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Sep 16, 2023

Correspondence

Form CORRESP - Correspondence